335207-46-0 Usage
Description
1-(2-MORPHOLIN-4-YL-2-OXO-ETHYL)-1H-INDOLE-3-CARBALDEHYDE is a chemical compound with a molecular formula C16H18N2O3, belonging to the class of indole derivatives. It features a morpholine group, an oxoethyl group, and a carbaldehyde group, which contribute to its potential applications in medicinal chemistry and drug discovery. 1-(2-MORPHOLIN-4-YL-2-OXO-ETHYL)-1H-INDOLE-3-CARBALDEHYDE exhibits pharmacological activities and biological properties, making it a valuable building block for the synthesis of biologically active molecules and pharmaceutical drugs. Its unique structure and properties are of significant interest for further research and development in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
1-(2-MORPHOLIN-4-YL-2-OXO-ETHYL)-1H-INDOLE-3-CARBALDEHYDE is used as a building block for the synthesis of biologically active molecules and pharmaceutical drugs due to its unique structural features and pharmacological activities.
Used in Medicinal Chemistry:
1-(2-MORPHOLIN-4-YL-2-OXO-ETHYL)-1H-INDOLE-3-CARBALDEHYDE is used as a compound with potential applications in medicinal chemistry, where its biological properties and pharmacological activities can be harnessed for the development of new drugs and therapies.
Used in Drug Discovery:
1-(2-MORPHOLIN-4-YL-2-OXO-ETHYL)-1H-INDOLE-3-CARBALDEHYDE is used as a starting point for drug discovery, as its structural features and properties make it an important chemical entity for the identification and development of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 335207-46-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,5,2,0 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 335207-46:
(8*3)+(7*3)+(6*5)+(5*2)+(4*0)+(3*7)+(2*4)+(1*6)=120
120 % 10 = 0
So 335207-46-0 is a valid CAS Registry Number.
335207-46-0Relevant articles and documents
New nucleotide-competitive non-nucleoside inhibitors of terminal deoxynucleotidyl transferase: Discovery, characterization, and crystal structure in complex with the target
Costi, Roberta,Cuzzucoli Crucitti, Giuliana,Pescatori, Luca,Messore, Antonella,Scipione, Luigi,Tortorella, Silvano,Amoroso, Alessandra,Crespan, Emmanuele,Campiglia, Pietro,Maresca, Bruno,Porta, Amalia,Granata, Ilaria,Novellino, Ettore,Gouge, Jéro?me,Delarue, Marc,Maga, Giovanni,Di Santo, Roberto
, p. 7431 - 7441 (2013/10/21)
Terminal deoxynucletidyl transferase (TdT) is overexpressed in some cancer types, where it might compete with pol μ during the mutagenic repair of double strand breaks (DSBs) through the nonhomologous end joining (NHEJ) pathway. Here we report the discove
